Molecular refinement of pilocytic astrocytoma in adult patients

Author:

Bode Helena12,Kresbach Catena1234,Holdhof Dörthe12,Dorostkar Mario M.56,Harter Patrick N.57,Hench Jürgen8,Frank Stephan8,Suwala Abigail K.910,Schweizer Leonille71112,Eckhardt Alicia1213,Neyazi Sina12,Bockmayr Michael124,Wefers Annika K.34ORCID,Schüller Ulrich123ORCID

Affiliation:

1. Department of Pediatric Hematology and Oncology University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Research Institute Children's Cancer Center Hamburg Hamburg Germany

3. Institute of Neuropathology University Medical Center Hamburg‐Eppendorf Hamburg Germany

4. Mildred Scheel Cancer Career Center HaTriCS4 University Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Center for Neuropathology Ludwig‐Maximilians‐University Munich Germany

6. Karl Landsteiner Privatuniversität für Gesundheitswissenschaften Saint Pölten Austria

7. Neurological Institute (Edinger Institute), University Hospital Frankfurt Goethe‐University Frankfurt am Main Germany

8. Division of Neuropathology, Institute of Medical Genetics and Pathology University of Basel Basel Switzerland

9. Department of Neuropathology, Institute of Pathology Heidelberg University Hospital Heidelberg Germany

10. Clinical Cooperation Unit Neuropathology German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK) Heidelberg Germany

11. Frankfurt Cancer Institute (FCI) Frankfurt am Main Germany

12. German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz German Cancer Research Center (DKFZ) Heidelberg Germany

13. Lab of Radiobiology and Experimental Radiation Oncology, Hubertus Wald Tumorzentrum—University Cancer Center Hamburg University Medical Center Hamburg‐Eppendorf Hamburg Germany

Abstract

AbstractAimPilocytic astrocytomas (PA) in adults are rare and may be challenging to identify based only on histomorphology. Compared to their paediatric counterparts, they are reportedly molecularly more diverse and associated with a worse prognosis. We aimed to describe the characteristics of adult PAs more precisely by comprehensively profiling a series of 79 histologically diagnosed adult cases (≥18 years).MethodsWe performed global DNA methylation profiling and DNA and RNA panel sequencing and integrated the results with clinical data. We further compared the molecular characteristics of adult and paediatric PAs that had a significant match to one of the established PA methylation classes in the Heidelberg brain tumour classifier.ResultsThe mean age in our cohort was 33 years, and 43% of the tumours were located supratentorially. Based on methylation profiling, only 39% of the cases received a significant match to a PA methylation class. Sixteen per cent matched a different tumour type, and 45% had a Heidelberg classifier score <0.9 with an affiliation to diverse established methylation classes in t‐SNE analyses. Although the KIAA1549::BRAF fusion was found in 98% of paediatric PAs, this was true for only 27% of histologically defined and 55% of adult PAs defined by methylation profiling.ConclusionsA particularly high fraction of adult tumours with histological features of PA do not match current PA methylation classes, indicating ambiguous histology and an urgent need for molecular profiling. Moreover, even in adult PAs with a match to a PA methylation class, the distribution of genetic drivers differs significantly from their paediatric counterparts (p < 0.01).

Funder

Fördergemeinschaft Kinderkrebs-Zentrum Hamburg

Deutsche Krebshilfe

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3